Efficacy of Olaparib (O) Plus Abiraterone (A) Versus Placebo (P) Plus A in Patients (pts) with Metastatic Castration-Resistant Prostate Cancer (mcrpc) with Single Homologous Recombination Repair Gene Mutations (hrrm) in the PROpel Trial.
JOURNAL OF CLINICAL ONCOLOGY(2024)
关键词
Alpha Particle Therapy,Metastatic Prostate Cancer
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要